EXECUTIVE LEADERSHIP SERIES

ASHTON TWEED'S EXECUTIVE INTERVIEWS

November 9, 2020

CEO Leadership Series: A Biopharma Executive’s Next Act in Developing Life-Changing Treatments

When Susan Dillon co-founded Aro Biotherapeutics in 2018, she had already led teams of researchers at Johnson & Johnson to develop revolutionary drugs for autoimmune diseases—Remicade®, Simponi, Stelara® and Tremfya®.
portrait of a businessman and a businesswoman leader

ARE YOU A CEO INTERESTED IN JOINING OUR LEADERSHIP SERIES?

CONTACT US TO DISCUSS AN INTERVIEW:

Jordan Warshafsky
Partner, Ashton Tweed Ltd.
Email: JWarshafsky@ashtontweed.com
Phone: 610.725.0290 x441

Ashton Tweed, Ltd.
314 S. Henderson Rd.
Suite G370
King of Prussia, PA 19406